Disputes and regulatory enforcement

Featured guidance
Disputes and regulatory enforcement guidance:

In recent years, we have witnessed a constantly growing interest from all stakeholders (the general public, patients associations, physicians, pharmaceutical industry and...

Practice Note

CASE HUB See further, timeline, commentary and related cases. Case facts OutlineCMA Article 102 TFEU/Chapter II investigation into Actavis UK in relation to an alleged...

Practice Note

CASE HUB See further, timeline ,commentary and related cases. Case facts OutlineCMA Article 101 TFEU/Chapter I investigation into AMCo (now Advanz Pharma Services (UK)...

Practice Note

Arbitration is a procedure in which a dispute is submitted, by agreement of the parties, to one or more arbitrators who make a binding decision on the dispute. In...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the decision of 23 January 2018; it is no longer maintained. See further: timeline,...

Practice Note

ARCHIVED—this achieved case hub reflects the position at the date of the decision of 12 December 2018; it is no longer maintained. NOTE—appeals lodged...

Practice Note

CASE HUB ARCHIVED–this archived case hub reflects the position at the date of the judgment of 8 September 2016; it is no longer maintained. See further: timeline,...

Practice Note

BREXIT: The law and practice referred to in this Practice Note may be impacted by Brexit. For further information on the potential impact, see: The effect of Brexit on UK...

Practice Note

This Practice Note compares and contrasts, at a high level and in table form, the key differences between arbitration and other forms of alternative dispute resolution...

Practice Note

A common IP dispute is where one party—in this note usually the claimant—alleges infringement of its patent and the defendant challenges the patent’s validity. Such...

Practice Note

Introduction to the medicines advertising enforcement landscape Directive 2001/83/EC on the Community code relating to medicinal products for human use...

Practice Note

The European Commission investigates evidences or allegations of anti-competitive behaviour by companies that has an impact in more than one EU country—for example,...

Practice Note

CASE HUB See further, timeline, commentary andrelated cases Case facts OutlineCMA Article 101 TFEU/Chapter I and Article 102 TFEU/Chapter II investigation into Aspen’s...

Practice Note

CASE HUB (Appeals lodged at the Competition Appeal Tribunal–see GlaxoSmithKline and other v CMA (paroxetine)) ARCHIVED–this archived case hub reflects the position at the...

Practice Note

NOTE—national reference lodged before the Court of Justice in Case C- 307/18 See further, timeline and related cases. Case facts OutlineGenerics UK Limited v CMA...

Practice Note

CASE HUB See further, timeline, commentary and related cases. Case facts OutlineCMA Article 101 TFEU/Chapter I investigation into Actavis UK and Concordia in relation to...

Practice Note